Trials / Completed
CompletedNCT01097980
Trazodone for SSRI-sexual Dsyfunction
The Efficacy of Trazodone for Selective Serotonin Reuptake Inhibitor-induced Sexual Dysfunction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Beitou Armed Forces Hospital, Taipei, Taiwan · Other Government
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the efficacy of trazodone in the treatment of selective serotonin reuptake inhibitor(s) associated sexual dysfunction. The secondary domains assessed were the relationship between 5-HT2A polymorphism and treatment efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trazodone | 50 mg/d trazodone was upwardly titrated to 100 mg/d over one week and then maintained |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2012-01-01
- Completion
- 2012-01-01
- First posted
- 2010-04-02
- Last updated
- 2012-04-24
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01097980. Inclusion in this directory is not an endorsement.